Palivizumab
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1520 publications
Nirsevimab for respiratory syncytial virus prevention: A comprehensive product review.
Journal: Human vaccines & immunotherapeutics
Published: September 03, 2026
Palivizumab for respiratory syncytial virus immunoprophylaxis in high-risk populations in Qatar: a call for action.
Journal: Expert review of anti-infective therapy
Published: July 20, 2026
RSV prophylactics for pediatric populations: A product review and meta-analysis of real-world effectiveness.
Journal: Human vaccines & immunotherapeutics
Published: June 25, 2026
Construction and verification of infectious clones for human respiratory syncytial virus subgroup A genotype ON1 expressing fluorescent reporter genes
Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
Published: June 22, 2026
Palivizumab for Donor-Derived RSV Infection in an Adult Bilateral Lung Transplant Recipient: A Case Report.
Journal: Respirology case reports
Published: June 06, 2026
Phylodynamics and molecular epidemiology of the respiratory syncytial virus fusion protein in China.
Phylodynamics and molecular epidemiology of the respiratory syncytial virus fusion protein in China.
Journal: Microbiology spectrum
Published: May 01, 2026
Early-Life Viral Lower Respiratory Tract Infections and Their Impact on Childhood Asthma: Molecular Endotypes and Prevention Strategies.
Journal: Pediatric allergy, immunology, and pulmonology
Published: April 28, 2026
Advances in respiratory syncytial virus therapeutics: A comprehensive review of small-molecule inhibitors, monoclonal antibodies, and vaccines.
Journal: European journal of medicinal chemistry
Published: April 23, 2026
Last Updated: 09/26/2026